Please ensure Javascript is enabled for purposes of website accessibility

obesity drugs

Pfizer to buy Metsera in $5B obesity drug deal
Sep 22, 2025

Pfizer to buy Metsera in $5B obesity drug deal

Pfizer will acquire Metsera for nearly $5B, boosting its push into obesity treatments with potential oral and injectable drugs.

Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition
Sep 10, 2025

Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth opportunities in obesity and diabetes medications. The restructuring, which would eliminate 11% of the company’s workforce, aimed to reduce organizational [&hellip[...]

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.